SCHEMBL17055674

SCHEMBL17055674

Cc1ccc2nnc(-c3ccc(F)cc3)n2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
MAPK14 Q16539 9/20 0.52
ALDH1A1 P00352 2/20 0.48
HSD17B10 Q99714 2/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
SCN5A Q14524 1/20 0.47
ALDH1A3 P47895 1/20 0.46
PIM1 P11309 1/20 0.44
SRC P12931 1/20 0.44
GSK3A P49840 1/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB2 P47870 1/20 0.44
NR1H4 Q96RI1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9844320 0.82 KDM4E (0.49) KDM4EMAPK14ALDH1A1HSD17B10HPGD
SCHEMBL13757325 0.82 KDM4E (0.57) KDM4EALDH1A1HSD17B10HPGDSCN5A
SCHEMBL32665400 0.81 KDM4E (0.57) KDM4EMAPK14ALDH1A1HSD17B10HPGD
SCHEMBL14773396 0.81 KDM4E (0.53) KDM4EMAPK14ALDH1A1HSD17B10HPGD
SCHEMBL13757339 0.81 KDM4E (0.50) KDM4EALDH1A1HSD17B10HPGDHTT
SCHEMBL15007181 0.77 MAPK14 (0.60) KDM4EMAPK14HSD17B10HPGDSCN5A
SCHEMBL23547235 0.75 PIM1 (0.58) KDM4EMAPK14ALDH1A1HSD17B10HPGD
SCHEMBL11415066 0.74 SCN5A (0.61) KDM4EMAPK14SCN5AALDH1A3PIM1
SCHEMBL30498960 0.74 KDM4E (1.00) KDM4EMAPK14ALDH1A1HSD17B10HPGD
SCHEMBL17055676 0.73 FLT3 (0.58) ALDH1A1HPGDALDH1A3TP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150246902-A1 SUBSTITUED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2015-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150246902-A1 SUBSTITUED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES EIF5B, EIF2AK2, HCCS KDM4E 2423/4885MAPK14 3355/4885ALDH1A1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.